论文部分内容阅读
采用酶免疫法检测104例慢性肝病和164例献血员丙型肝炎抗体(抗-HCV),阳性率分别为18.3%(19/104)、1.8%(3/164);慢性肝病中HBV/HCV双重感染13例。HBV/HCV双重感染组(B组)与单纯丙型肝炎组(A组)谷丙转氨酶(ALT)差异无显著性(P>0.05)。与单纯慢性乙型肝炎组(C组)ALT差异有显著性(P<0.05);3组间血清总胆红素差异有显著性(P<0.05)。本文结果表明:HBV/HCV双重感染可加重肝脏损害,多数病例未见HBV与HCV干扰现象;正常人群也存在丙型肝炎隐性感染。
104 cases of chronic liver disease and 164 cases of blood donors hepatitis C antibody (anti-HCV) were detected by enzyme immunoassay. The positive rates were 18.3% (19/104) and 1.8% (3/164) respectively. Chronic liver disease HBV / HCV double infection in 13 cases. There was no significant difference in alanine aminotransferase (ALT) between HBV / HCV infected group (group B) and hepatitis C group (group A) (P> 0.05). (P <0.05). The difference of serum total bilirubin between the three groups was significant (P <0.05). The results show that: HBV / HCV double infection can aggravate liver damage, most cases did not have HBV and HCV interference; normal population also exists latent hepatitis C infection.